Lataa...
Neurotrophic Growth Factors for the Treatment of Amyotrophic Lateral Sclerosis: Where Do We Stand?
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that results in progressive loss of motoneurons, motor weakness and death within 3–5 years after disease onset. Therapeutic options remain limited despite substantial number of approaches that have been tested clinically....
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Research Foundation
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2902233/ https://ncbi.nlm.nih.gov/pubmed/20592948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2010.00032 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|